Giuseppe Maria Maruotti

Giuseppe Maria Maruotti

Auto-generated profile, based on publicly available information

Giuseppe Maria Maruotti

A Department of Neuroscience, Reproductive Sciences and Dentistry , School of Medicine, University of Naples "Federico II" , Naples , Italy

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
GSGabriele Saccone
Gabriele Saccone
VBVincenzo Berghella
Vincenzo Berghella
GMGiuseppe Maria Maruotti
Giuseppe Maria Maruotti
TGTullio Ghi
Tullio Ghi
Giuseppe RizzoGiuseppe Rizzo
Giuseppe Rizzo
PMPasquale Martinelli
Pasquale Martinelli

19 December 2017 in JAMA
Verified
Journal Article
Open access
PDF file
GSGabriele Saccone
Gabriele Saccone
GMGiuseppe Maria Maruotti
Giuseppe Maria Maruotti
AGAntonia Giudicepietro
Antonia Giudicepietro
PMPasquale Martinelli
Pasquale Martinelli
FGfor the Italian Preterm Birth Prevention (IPP) Working Group
for the Italian Preterm Birth Prevention (IPP) Working Group
Importance Spontaneous preterm birth is a major cause of perinatal morbidity and mortality. It is unclear if a cervical pessary can reduce the risk of spontaneous preterm delivery. Objective To test whether in asymptomatic women with singleton pregnancies and no prior spontaneous preterm birth but with short cervical length on transvaginal ultrasound, use of a cervical pessary would reduce the rate of spontaneous preterm birth at less than 34 weeks of gestation. Design, Setting, and Participants Parallel-group, nonblinded, randomized clinical trial conducted from March 1, 2016, to May 25, 2017, at a single center in Italy. Asymptomatic women with singleton gestations, no previous spontaneous preterm births, and cervical lengths of 25 mm or less at 18 weeks 0 days to 23 weeks 6 days of gestation were eligible. Interventions Patients were randomized 1:1 to receive either cervical pessary (n = 150) or no pessary (n = 150). The pessary was removed between 37 weeks 0 days and 37 weeks 6 days of gestation or earlier if clinically indicated. The control group received standard care. For cervical length of 20 mm or shorter, women in both groups were prescribed vaginal progesterone, 200 mg/d, until 36 weeks 6 days of gestation. No bed rest or activity restriction was recommended. Main Outcomes and Measures The primary end point was spontaneous preterm birth at less than 34 weeks of gestation. Secondary outcomes were adverse events. Results Among 300 women who were randomized (mean age, 29 [SD, 6.3] years; mean gestational age, 22 [SD, 1.3] weeks), 100% completed the trial. The primary end point occurred in 11 women (7.3%) in the pessary group and 23 women (15.3%) in the control group (between-group difference, −8.0% [95% CI, −15.7% to −0.4]; relative risk, 0.48 [95% CI, 0.24-0.95]). During follow-up, the pessary group had a higher rate of increased or new vaginal discharge (86.7% vs 46.0%; between-group difference, +40.7% [95% CI, +30.1%-+50.3%]; relative risk, 1.88 [95% CI, 1.57-2.27]). Conclusions and Relevance Among women without prior spontaneous preterm birth who had asymptomatic singleton pregnancies and short transvaginal cervical length, use of a cervical pessary, compared with no pessary use, resulted in a lower rate of spontaneous preterm birth at less than 34 weeks of gestation. The results of this single-center, nonblinded study among selected pregnant women require confirmation in multicenter clinical trials. Trial Registration clinicaltrials.gov Identifier:NCT02716909

24 January 2013 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
Morlando MaddalenaMorlando Maddalena
Morlando Maddalena
LSLaura Sarno
Laura Sarno
RNRaffaele Napolitano
Raffaele Napolitano
ACAngela Capone
Angela Capone
GTGiovanni Tessitore
Giovanni Tessitore
PMPasquale Martinelli
Pasquale Martinelli
Placenta accreta is a rare and potentially life‐threatening complication of pregnancy characterized by abnormal adherence of the placenta to the uterine wall. A previously scarred uterus or an abnormal site of placentation in the lower segment is a major risk factor. The aim of this study was to investigate the change in the incidence of placenta accreta and associated risk factors along four decades, from the 1970s to 2000s, in a tertiary south Italian center. We analyzed all cases of placenta accreta in a sample triennium for each decade. The incidence increased from 0.12% during the 1970s, to 0.31% during the 2000s. During the same period, cesarean section rates increased from 17 to 64%. Prior cesarean section was the only risk factor showing a significant concomitant rise. Our results reinforce cesarean section as the most significant predisposing condition for placenta accreta.

1 February 2016 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
GSGabriele Saccone
Gabriele Saccone
VBVincenzo Berghella
Vincenzo Berghella
LSLaura Sarno
Laura Sarno
GMGiuseppe M. Maruotti
Giuseppe M. Maruotti
ICIrene Cetin
Irene Cetin
PMPasquale Martinelli
Pasquale Martinelli

11 April 2017 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
GSGabriele Saccone
Gabriele Saccone
ACAndrea Ciardulli
Andrea Ciardulli
SXSerena Xodo
Serena Xodo
LDLorraine Dugoff
Lorraine Dugoff
JLJack Ludmir
Jack Ludmir
VBVincenzo Berghella
Vincenzo Berghella

4 January 2017 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
GSGabriele Saccone
Gabriele Saccone
ACAndrea Ciardulli
Andrea Ciardulli
SXSerena Xodo
Serena Xodo
LDLorraine Dugoff
Lorraine Dugoff
JLJack Ludmir
Jack Ludmir
VBVincenzo Berghella
Vincenzo Berghella
Objective: To evaluate the effectiveness of cervical pessary for preventing spontaneous preterm birth (SPTB) in twin pregnancies with an asymptomatic transvaginal ultrasound cervical length (TVU CL) in the second trimester. Methods: We performed a meta-analysis including all randomized clinical trials (RCTs) comparing the use of cervical pessary (i.e. intervention group) with expectant management (i.e. control group). The primary outcome was incidence of SPTB <34 weeks. Results: Three trials, including 481 twin pregnancies with short cervix, were analyzed. Two RCTs defined short cervix as TVU CL ≤25 mm and one as TVU CL ≤38 mm. Pessary was not associated with prevention of SPTB, and the mean gestational age at delivery and the mean latency were similar in the pessary group compared to the control group. Moreover, no benefits were noticed in neonatal outcomes. Conclusions: Use of the Arabin pessary in twin pregnancies with short TVU CL at 16–24 weeks does not prevent SPTB or improve perinatal outcome.